Form 8-K - Current report:
SEC Accession No. 0000059478-25-000271
Filing Date
2025-11-21
Accepted
2025-11-21 16:19:05
Documents
13
Period of Report
2025-11-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K lly-20251118.htm   iXBRL 8-K 48304
  Complete submission text file 0000059478-25-000271.txt   254480

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20251118.xsd EX-101.SCH 4275
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20251118_def.xml EX-101.DEF 19144
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20251118_lab.xml EX-101.LAB 36789
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20251118_pre.xml EX-101.PRE 20303
15 EXTRACTED XBRL INSTANCE DOCUMENT lly-20251118_htm.xml XML 9814
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 251508243
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)